Metronomic scheduling of anticancer treatment: the next generation of multitarget therapy?

Evading tumor evasion: Current concepts and perspectives of anti-angiogenic cancer therapy

(2010) Amir Abdollahi et al.   DRUG RESISTANCE UPDATES

Strategies for Prolonged Therapy in Patients With Advanced Non–Small-Cell Lung Cancer

(2010) Panos Fidias et al.   JOURNAL OF CLINICAL ONCOLOGY

Looking at the Seemingly Contradictory Role of Vinblastine in Anaplastic Large-Cell Lymphoma From a Metronomic Perspective

(2010) Nicolas André et al.   JOURNAL OF CLINICAL ONCOLOGY

Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents

(2010) Jiahuai Tan et al.   Journal of Hematology & Oncology

Nontoxic, Fiscally Responsible, Future of Oncology

(2010) Giannoula Lakka Klement et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Children Treated With Metronomic Chemotherapy in a Low-income Country

(2010) Traore Fousseyni et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

A Phase 1 Study of Nifurtimox in Patients With Relapsed/Refractory Neuroblastoma

(2010) Giselle L. Saulnier Sholler et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial

(2010) Axel Le Cesne et al.   LANCET ONCOLOGY

Metronomic chemotherapy: new rationale for new directions

(2010) Eddy Pasquier et al.   Nature Reviews Clinical Oncology

Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma

(2010) Christian Steidl et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety, Tolerability and Biological Effects of Long-Term Metronomic Administration of Non-Cytotoxic Anti-Angiogenic Agents

(2010) Cristina Noberasco et al.   ONCOLOGY

Tumour-microenvironmental interactions: paths to progression and targets for treatment

(2010) Carol Box et al.   SEMINARS IN CANCER BIOLOGY

Maintenance therapy in nonsmall-cell lung cancer

(2009) Tony S. K. Mok et al.   CANCER

Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model

(2009) Claire Banissi et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Dual Therapeutic Efficacy of Vinblastine as a Unique Chemotherapeutic Agent Capable of Inducing Dendritic Cell Maturation

(2009) H. Tanaka et al.   CANCER RESEARCH

Paclitaxel and immune system

(2009) Aqeel Javeed et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Single-Drug Vinblastine As Salvage Treatment for Refractory or Relapsed Anaplastic Large-Cell Lymphoma: A Report From the French Society of Pediatric Oncology

(2009) Laurence Brugières et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase I/II Trial of Metronomic Chemotherapy With Daily Dalteparin and Cyclophosphamide, Twice-Weekly Methotrexate, and Daily Prednisone As Therapy for Metastatic Breast Cancer Using Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor Levels As Markers of Response

(2009) Nan Soon Wong et al.   JOURNAL OF CLINICAL ONCOLOGY

Nifurtimox Induces Apoptosis of Neuroblastoma Cells In Vitro and In Vivo

(2009) Giselle L. Saulnier Sholler et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

A change of strategy in the war on cancer

(2009) Robert A. Gatenby   NATURE

For cancer, seek and destroy or live and let live?

(2009) Nicolas André et al.   NATURE

Enhancing CD8 T-cell memory by modulating fatty acid metabolism

(2009) Erika L. Pearce et al.   NATURE

Biomarkers of response and resistance to antiangiogenic therapy

(2009) Rakesh K. Jain et al.   Nature Reviews Clinical Oncology

Phase II Study of Metronomic Chemotherapy with Thalidomide, Carboplatin-Vincristine-Fluvastatin in the Treatment of Brain Stem Tumors in Children

(2008) Enrique López-Aguilar et al.   ARCHIVES OF MEDICAL RESEARCH

Combining Agents that Target the Tumor Microenvironment Improves the Efficacy of Anticancer Therapy

(2008) J. A. Blansfield et al.   CLINICAL CANCER RESEARCH

Metronomic etoposide/cyclophosphamide/celecoxib regimen given to children and adolescents with refractory cancer: A preliminary monocentric study

(2008) Nicolas André et al.   CLINICAL THERAPEUTICS

Cancer Stem Cells: How can we Target them?

(2008) Ivan Ischenko et al.   CURRENT MEDICINAL CHEMISTRY

Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations

(2008) J LOPICCOLO et al.   DRUG RESISTANCE UPDATES

Metronomic scheduling of imatinib abrogates clonogenicity of neuroblastoma cells and enhances their susceptibility to selected chemotherapeutic drugsin vitroandin vivo

(2008) Ebba Palmberg et al.   INTERNATIONAL JOURNAL OF CANCER

The anticancer immune response: indispensable for therapeutic success?

(2008) Laurence Zitvogel et al.   JOURNAL OF CLINICAL INVESTIGATION

Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and Angiogenesis

(2008) Christine E. Eyler et al.   JOURNAL OF CLINICAL ONCOLOGY

Stromal gene expression predicts clinical outcome in breast cancer

(2008) Greg Finak et al.   NATURE MEDICINE

The tumour microenvironment: a novel target for cancer therapy

(2008) E Hanna et al.   ORAL DISEASES

PPAR  agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition

(2008) D. Panigrahy et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Why does cytotoxic chemotherapy cure only some cancers?

(2008) Philip Savage et al.   Nature clinical practice. Oncology